| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $8.9M | -31.7% |
| SG&A Expense | $12.9M | -19.3% |
| Operating Income | -$21.8M | +24.9% |
| Interest Expense | $700K | -36.4% |
| Pre-tax Income | -$22.2M | +24.0% |
| Income Tax | $14K | -12.5% |
| Net Income | -$22.1M | +24.2% |
| EPS (Basic) | -$2.97 | -271.7% |
| EPS (Diluted) | -$2.97 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.6M | — |
| Current Assets | $10.2M | +137.7% |
| Total Assets | $14.2M | +41.6% |
| Current Liabilities | $9.5M | -7.2% |
| Long-term Debt | $600K | -70.9% |
| Total Liabilities | $12.2M | -33.1% |
| Stockholders' Equity | $1.5M | +118.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.7M | +27.0% |
| Investing Cash Flow | -$16K | +96.7% |
| Financing Cash Flow | $27.4M | -5.8% |
| -271.7% |